{4-[(tert-Butoxycarbonyl)amino]phenyl}acetic acid, 97.0%, 5g

3-(propan-2-yl)azetidin-3-ol hydrochloride, 95.0%, 1g

1-{3-[(2-fluorophenyl)methyl]-1,2,4-thiadiazol-5-yl}piperazine, 95.0%, 2g

Pyridazine-4-carboxylic Acid>98.0%(GC)(T)1g

3-Bromo-1,1,1-trifluoro-2-butanone, 95.0%, 5g

3'-Bromophenyl acetylene, 97.0%, 10g

Pipette tips Mμlti® Flex 1-200 μl, flat 0.4 mm, Box, Non-sterile, 200 Pieces

(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95.0%, 25g

1-Chloro-5-methyl-2,4-dinitrobenzene, 95.0%, 25g

2-Oxo-butyric acid ethyl ester, 95.0%, 10g

(E)-2-(2-(4-(DIMETHYLAMINO)STYRYL)-6-METHYL-4H-PYRAN-4-YLIDENE)MALONONITRILE, 95.0%, 5g

2,4-Dichloro-6-(methylthio)-1,3,5-triazine, 95.0%, 100mg

(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-carbamoylphenyl)propanoic acid, 95+%, 1g